Abstract
Monoclonal antibodies (mAb) are potent agents with significant therapeutic advantages and represent the new standard of care in oncology. Although fairly well tolerated, a major health issue with mAbs is the development of infusion reactions that can range in severity from mild to life threatening. Therefore, it is critical to know how to manage these reactions when the first symptoms appear. Oncology nurses need to be proactive in monitoring, assessing, and managing infusion reactions throughout the entire course of therapy. Nurses are also instrumental in developing a protocol on how to address infusion reactions. Building a partnership with patients and caregivers ensures that patients are safely treated and can fully benefit from mAb therapy.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Algorithms
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / chemistry
-
Antibodies, Monoclonal / pharmacology
-
Decision Trees
-
Drug Hypersensitivity* / diagnosis
-
Drug Hypersensitivity* / etiology
-
Drug Hypersensitivity* / prevention & control
-
Drug Monitoring / nursing
-
Emergency Treatment / methods
-
Emergency Treatment / nursing
-
Humans
-
Immunologic Factors / adverse effects*
-
Immunologic Factors / chemistry
-
Immunologic Factors / pharmacology
-
Infusions, Intravenous / nursing
-
Male
-
Middle Aged
-
Neoplasms / therapy*
-
Nurse's Role
-
Nursing Assessment
-
Oncology Nursing / methods*
-
Severity of Illness Index
Substances
-
Antibodies, Monoclonal
-
Immunologic Factors